Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122485576 | 12248557 | 6 | F | 20160321 | 20160706 | 20160408 | 20160713 | EXP | GB-AMGEN-GBRSP2016041326 | AMGEN | 66.00 | YR | E | M | Y | 0.00000 | 20160712 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122485576 | 12248557 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | U | 125031 | 6 | MG | UNKNOWN FORMULATION | ||||||
| 122485576 | 12248557 | 2 | SS | denosumab | DENOSUMAB | 1 | Unknown | 120 MG, UNK | U | 0 | 120 | MG | UNKNOWN FORMULATION | ||||||
| 122485576 | 12248557 | 3 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 675 MG, UNK | 0 | 675 | MG | ||||||||
| 122485576 | 12248557 | 4 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 675 MG, UNK | 0 | 675 | MG | ||||||||
| 122485576 | 12248557 | 5 | SS | APREPITANT. | APREPITANT | 1 | Unknown | UNK | 0 | ||||||||||
| 122485576 | 12248557 | 6 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | 156 MG, UNK | 0 | 156 | MG | ||||||||
| 122485576 | 12248557 | 7 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | 156 MG, UNK | 0 | 156 | MG | ||||||||
| 122485576 | 12248557 | 8 | SS | PEMETREXED | PEMETREXED | 1 | Unknown | 1050 MG, UNK | 0 | 1050 | MG | ||||||||
| 122485576 | 12248557 | 9 | SS | PEMETREXED | PEMETREXED | 1 | Unknown | 1050 MG, UNK | 0 | 1050 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122485576 | 12248557 | 1 | Product used for unknown indication |
| 122485576 | 12248557 | 3 | Product used for unknown indication |
| 122485576 | 12248557 | 5 | Product used for unknown indication |
| 122485576 | 12248557 | 6 | Product used for unknown indication |
| 122485576 | 12248557 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122485576 | 12248557 | OT |
| 122485576 | 12248557 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122485576 | 12248557 | Alopecia | |
| 122485576 | 12248557 | Contusion | |
| 122485576 | 12248557 | Cough | |
| 122485576 | 12248557 | Decreased appetite | |
| 122485576 | 12248557 | Dehydration | |
| 122485576 | 12248557 | Dizziness | |
| 122485576 | 12248557 | Dysgeusia | |
| 122485576 | 12248557 | Dyspnoea | |
| 122485576 | 12248557 | Epistaxis | |
| 122485576 | 12248557 | Fall | |
| 122485576 | 12248557 | Fatigue | |
| 122485576 | 12248557 | Flushing | |
| 122485576 | 12248557 | Headache | |
| 122485576 | 12248557 | Hypersomnia | |
| 122485576 | 12248557 | Joint swelling | |
| 122485576 | 12248557 | Malaise | |
| 122485576 | 12248557 | Melaena | |
| 122485576 | 12248557 | Neuropathy peripheral | |
| 122485576 | 12248557 | Ocular hyperaemia | |
| 122485576 | 12248557 | Paraesthesia | |
| 122485576 | 12248557 | Rhinorrhoea | |
| 122485576 | 12248557 | Somnolence | |
| 122485576 | 12248557 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122485576 | 12248557 | 1 | 20160322 | 0 | ||
| 122485576 | 12248557 | 3 | 20160321 | 0 | ||
| 122485576 | 12248557 | 6 | 20160321 | 0 | ||
| 122485576 | 12248557 | 8 | 20160321 | 0 |